MeMed

MeMed is an Israel-based biotechnology firm that develops and commercializes diagnostic products for the treatment of infectious diseases and inflammatory disorders.

Business Model:

Revenue: $5M

Employees: 51-200

Detailed MeMed Information

Geographic Data

MeMed headquarters map

Address: 5 Nahum Het Street

City: Tirat Karmel

State: haifa district

Zip: 39120

Country: IL

Financial Info

Stage:

series unknown

Raised Last:

$93M

Raised Total:

$167M

Metrics

2,325,231Website Global Rank

8,053Website Monthly Traffic

Twitter Followers

Description

MeMed is an Israel-based biotechnology firm that develops and commercializes diagnostic products for the treatment of infectious diseases and inflammatory disorders.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2022 Venture Round $0 Caesarea Medical Electronics
Clal Insurance Enterprises Holdings
Horizons Ventures
La Maison Partners
Phoenix Insurance
Poalim Equity
Shavit Capital
Social Capital
Touchwood Capital
Union Tech Ventures
Western Technology Investment
Caesarea Medical Electronics
Clal Insurance Enterprises Holdings
Horizons Ventures
La Maison Partners
Phoenix Insurance
Poalim Equity
Shavit Capital
Social Capital
Touchwood Capital
Union Tech Ventures
Western Technology Investment
8/2013 Series B 1 - Social Capital
Social Capital
2/2018 Grant 1 $4.1M Congressionally Directed Medical Research Programs
Congressionally Directed Medical Research Programs
11/2019 Grant 2 $2.8M European Innovation Council
Poalim Equity
European Innovation Council
Poalim Equity
9/2018 Series C $0 Caesarea Medical Electronics
Clal Insurance Enterprises Holdings
Foxconn Technology Group
Horizons Ventures
Li Ka-shing
OurCrowd
Phoenix Insurance Company
Ping An Global Voyager
Social Capital
Western Technology Investment
Caesarea Medical Electronics
Clal Insurance Enterprises Holdings
Foxconn Technology Group
Horizons Ventures
Li Ka-shing
OurCrowd
Phoenix Insurance Company
Ping An Global Voyager
Social Capital
Western Technology Investment
7/2015 Series C 2 - Social Capital
S28 Capital
Social Capital
S28 Capital
12/2015 Grant 1 $3.1M EASME - EU Executive Agency for SMEs
9/2011 Series A 1 - Social Capital
Social Capital
1/2022 Equity 11 $93M Horizons Ventures
Shavit Capital
Social Capital
La Maison Partners
Touchwood Capital
Union Tech Ventures
Caesarea Medical Holdings
Clal Insurance
Poalim Equity
Western Technology Investment
U.S. Department of Defense
EU Commission
Caesarea Medical Electronics
Clal Insurance Enterprises Holdings
Horizons Ventures
La Maison Partners
Phoenix Insurance
Poalim Equity
Shavit Capital
Social Capital
Touchwood Capital
Union Tech Ventures
Western Technology Investment
9/2018 Equity 10 $70M Foxconn
Caesarea Medical Holdings
Clal Insurance Enterprises Holdings Ltd
OurCrowd
Social Capital
WTI
Horizons Ventures
Ping An Insurance Group Co of China Ltd
Caesarea Medical Electronics
Clal Insurance Enterprises Holdings
Foxconn Technology Group
Horizons Ventures
Li Ka-shing
OurCrowd
Phoenix Insurance Company
Ping An Global Voyager
Social Capital
Western Technology Investment
7/2015 Series C 2 -
8/2013 Series B 1 -
9/2011 Series A 1 -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research